Nycomed Faces IP Suit Over Solaraze Gel
Pharmaceutical research company GlycoBioSciences Inc. filed suit in New York on Thursday against Nycomed US Inc., claiming that its Solaraze Gel skin condition treatment infringes two patents. ...To view the full article, register now.
Already a subscriber? Click here to view full article